派杰投资 PIPR 深 沪
已收盘 11-06 16:00:00 美东时间
65.92
-1.220
-1.82%
华盛通- 最 高67.52
- 今 开66.42
- 成交量 82.14万股
- 最 低 65.65
- 昨 收 67.14
- 总市值 44.23亿
- 52周最高 93.24
- 市盈率 静 16.67
- 换手率 0.00%
- 52周最低 61.35
- 委 比 -88.68%
- 总股本 6710.00万
- 历史最高 93.24
- 量 比 0.66
- 振 幅 2.79%
- 历史最低 -6.5025
- 每 手 1
- 风险率 6.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Orchestra BioMed Announces Pricing of Public Offering
Orchestra BioMed Holdings, Inc. announced the pricing of a public offering of 15,000,000 shares of common stock at $5.00 per share, with an additional 2,250,000 shares available under the underwriters' option. The gross proceeds are expected to be $75.0 million, to be used for funding the AVIM Therapy and Virtue SAB programs, clinical trials, and other product development. The offering is expected to close on November 9, 2026, with Piper Sandler ...
11-06 03:42
财报速睇 | 派杰投资 2026财年Q3营收4.43亿美元，同比下降7.56%；归母净利润0.55亿美元，同比下滑8.05%
华盛资讯11月6日讯，派杰投资公布2026财年Q3业绩，公司Q3营收4.43亿美元，同比下降7.56%，归母净利润0.55亿美元，同比下滑8.05%。
11-06 02:48
Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Shattuck Labs reported third-quarter 2026 financial results with $196.3 million in cash and highlighted advancements in their DR3-targeted therapies. The company initiated Phase 2b trials for SL-325 in Crohn’s disease and plans a Phase 2 trial for hidradenitis suppurativa. SL-846 showed promising preclinical data, with plans for a Phase 1 trial in 2027. Shattuck also announced upcoming presentations at industry conferences.
11-05 13:00
Piper Sandler Maintains Underweight on Innovative Ind Props, Raises Price Target to $46
Piper Sandler analyst Alexander Goldfarb maintains Innovative Ind Props (NYSE:IIPR) with a Underweight and raises the price target from $44 to $46.
11-05 01:17
Arista Networks Q3电话会：CEO称以太网AI客户超100家进入AI超级周期 首次指引2027营收185亿美元
Arista Networks发布截至9月30日的2026年第三季度业绩，并于同日盘后召开电话会。
11-04 10:18
安进(AMGN.US)Q3电话会：上调全年营收与EPS指引 管理层预计IMDELLTRA一线放量将非常迅速
本次电话会最受关注的问题不是超预期的幅度，而是IMDELLTRA(塔拉塔单抗)在ESMO大会上公布的一线维持治疗数据。
11-04 09:26
Take-Two (TTWO) Receives a Buy from Piper Sandler
In a report released yesterday, James Callahan CFA from Piper Sandler reiterate...
11-04 01:26
Beta Bionics Announces Participation at Upcoming Investor Conferences
Beta Bionics, Inc. announced that its management team will participate in several upcoming investor conferences in November and December 2026. Presentations will be held at the Wolfe Research Healthcare Conference on November 10, the Stifel Healthcare Conference on November 11, the Jefferies Global Healthcare Conference in London on November 18-19, and the Piper Sandler Healthcare Conference on December 2. All presentations will be available live...
11-03 12:30
